For laboratory research only. Not for human consumption.Our comparison method ↗
Studio-style Deals on Peptides product visual for NAD+

Vial comparison

NAD+ prices

Compare NAD+ listings by strength, selection and supplier. Inspect the original source behind each price.

47suppliers represented
87source-linked listings
6strengths available

MATCH SIZE AND QUANTITY

Build your comparison.

Daily snapshot · inspect sources

Choose a labeled amount and selection to load matching prices.

GO BEYOND THE PRICE

Track it. Plan it. Inspect it.

Select a strength and selection above to view price history, save a price watch or add it to your basket.

DOCUMENTATION PASSPORTS

Reports and batch records

Search all batch records

Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.

Loading documentation records…

Listed amounts and selections

  • 100 mg3 suppliers · Pack counts: 1
  • 250 mg1 supplier · Pack counts: 1
  • 500 mg39 suppliers · Pack counts: 1, 2, 3, 5, 6, 10
  • 700 mg3 suppliers · Pack counts: 1, 10
  • 1000 mg17 suppliers · Pack counts: 1, 2, 3, 5, 10
  • 4000 mg1 supplier · Pack counts: 1

Reported quantities in this family: 1, 2, 3, 5, 6, 10. Counts and units must be matched to the exact listing.

Compare the exact selection

Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.

Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.

Single-vial price overview

Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.

Listed total prices before additional promotions or coupon estimates. Includes supplier captures and aggregator reports; capture dates do not confirm current vendor price or stock. Shipping and tax extra. Open the source before relying on a price.
StrengthSelectionLowest listed total pricePrice per mgSupplier countCompare
100 mg1 vial$23.64$0.243Compare
250 mg1 vial$44.00$0.181Compare
500 mg1 vial$25.00$0.0537Compare
700 mg1 vial$73.75$0.113Compare
1000 mg1 vial$51.00$0.0516Compare
4000 mg1 vial$69.00$0.021Compare

Suppliers with NAD+ listings

47 profiles
View 41 more supplier profiles

Sources and comparison limits

8 listings from direct supplier captures and 79 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.

Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.

Explore more vial listings

Browse all products

FROM PEPTIDES CALCULATOR

About NAD+

Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, where it carries electrons through glycolysis and the citric acid cycle and serves as the substrate consumed by sirtuins, PARP enzymes and CD38. Tissue levels fall with age and with oxidative stress, which is the rationale behind the wellness industry's NAD-boosting products: oral precursors such as nicotinamide riboside and nicotinamide mononucleotide, and parenteral NAD+ itself given by intravenous drip or subcutaneous injection. It is not approved by the FDA for any indication, injectable forms are compounded preparations that receive no pre-market review, and a 2026 systematic review found no outcome trials at all of intravenous or intramuscular NAD+ for anti-aging or wellness use. Because it is a dinucleotide rather than a peptide, it has no amino acid sequence.

Formula
C21 H27 N7 O14 P2
Molar mass
663.4 g/mol
CAS number
53-84-9

Research evidence described in the source

Human

Small IV pharmacokinetic pilot

Eight participants received 750 mg NAD+ over six hours; the study measured metabolite handling, not clinical efficacy.

Review

Precursor evidence is not direct NAD+ evidence

Human NR and NMN trials cannot be automatically generalized to injected NAD+.

Review

Clinical outcomes remain inconclusive

Reviews find biochemical target engagement more consistently than meaningful health outcomes.

Limitations noted in the source

  • NAD+, NADH, NR, NMN, niacin, and nicotinamide are related but non-interchangeable interventions.
  • Direct IV/IM NAD+ lacks large randomized outcomes trials for anti-aging or wellness claims.
  • A calculator preset is a recorded research convention, not a recommendation or evidence of clinical benefit.
  • Identity, purity, sterility, and stability can vary substantially outside regulated manufacturing.
Publications and references linked by the source

Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.